The invention discloses a covalent
kinase inhibitor, a preparation method, a pharmaceutical composition and application, the structure of the covalent
kinase inhibitor is shown as a formula I, II, III, IV or V. The covalent
kinase inhibitor further comprises pharmaceutically acceptable salt of the covalent kinase inhibitor, and the covalent kinase inhibitor can be efficiently and covalently combined with target kinase and triggers NO / NO2-release at the same time. On one hand,
covalent binding can perform covalent inhibition on sulfydryl-containing target kinase, and on the other hand, released NO / NO2-can further generate sulfydryl
nitrosation modification on the target kinase or
protein interacting with the target kinase, so that self
phosphorylation of the target kinase is inhibited, kinase
signal transduction is prevented, and a synergistic effect is achieved; the compound can act on a plurality of kinases related to malignant tumor proliferation, has good selectivity and low off-target effect, can significantly inhibit the growth of
tumor cells at
cell and animal levels, and has no obvious adverse reaction. In addition, the preparation method is simple, convenient and universal, and is beneficial to expansion of parent
nucleus structures of other multiple kinase inhibitors. # imgabs0 #